# Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis

> **NCT00043316** · PHASE1,PHASE2 · COMPLETED · sponsor: **InterMune** · enrollment: 66 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** interferon gamma-1b

## Key facts

- **NCT ID:** NCT00043316
- **Lead sponsor:** InterMune
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** —
- **Final completion:** 2002-10
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2007-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043316, "Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00043316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*